1 / 51

Procedural Sedation in the Pre-Hospital Setting

Procedural Sedation in the Pre-Hospital Setting. Antoinette Eng, MD Albany Medical Center December 20, 2006. EMS Procedural Sedation: Overview. Definition Indications Medications Recent Research Summary. Sedation. Controlled reduction of environmental awareness. Sedation. Dynamic.

kina
Download Presentation

Procedural Sedation in the Pre-Hospital Setting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Procedural Sedation in the Pre-Hospital Setting Antoinette Eng, MD Albany Medical Center December 20, 2006

  2. EMS Procedural Sedation: Overview • Definition • Indications • Medications • Recent Research • Summary

  3. Sedation Controlled reduction of environmental awareness

  4. Sedation Dynamic

  5. Moderate Sedation & Analgesia Anxiolysis Deep Sedation & Analgesia Anesthesia A Clinical Spectrum

  6. Minimal Sedation • Drug-induced state • Impaired cognitive function & coordination • Responds to verbal commands • Ventilatory and cardiovascular functions intact Anxiolysis

  7. Previously known as “conscious sedation” • Depression of consciousness • Respond purposefully to verbal commands alone or with light tactile stimulation • Ventilation and cardiovascular function intact Anxiolysis Moderate Sedation & Analgesia

  8. Depression of consciousness • Not easily aroused, but responds purposefully after repeated or painful stimulation • May require airway and ventilatory support • Cardiovascular function maintained Anxiolysis Moderate Sedation & Analgesia Deep Sedation & Analgesia

  9. Loss of consciousness • Patient cannot be aroused by painful stimuli • Requires airway and ventilatory support • Cardiovascular function may be impaired Anxiolysis Moderate Sedation & Analgesia Deep Sedation & Analgesia Anesthesia

  10. Indications • Procedures Cardioversion Transcutaneous Pacing Pre/Post-Intubation Transport Extrication • Primary Treatment Anxiety Sympathomimetic Overdose Alcohol Withdrawal • Patient Restraint • Pain Management Adjunct Trauma Acute Abdomen ACS

  11. Indications • Procedures Cardioversion Transcutaneous Pacing Pre/Post-Intubation Transport Extrication • Primary Treatment Anxiety Sympathomimetic Overdose Alcohol Withdrawal • Patient Restraint • Pain Management Adjunct Trauma Acute Abdomen ACS

  12. Procedural Sedation: Medications • Benzodiazepines • Etomidate • Opiates • Nitrous Oxide

  13. Benzodiazepines

  14. Benzodiazepines • GABA is major inhibitory neurotransmitter in CNS • 3 types of receptors: GABA-A, GABA-B, GABA-C • GABA-A overwhelmingly numerically dominant receptor in CNS • BZO bind and allosterically modify receptor • Potentiate GABA response • Increase hyperpolarization • Increase neuronal inhibition at all levels of the neuraxis, including the spinal cord, hypothalamus, hippocampus, substantia nigra, cerebellar cortex, and cerebral cortex • Sedation, amnesia, muscle relaxation, anesthesia, anti-convulsant, anxiolytic

  15. Midazolam • lipid soluble in blood • Rapid GI absorption, • Lipid solubility = prompt passage across blood-brain barrier, rapid redistribution and short duration of action • Large first-pass hepatic effect • Metabolism slowed in patients on cimetidine, erythromycin, calcium channel blockers, antifungal medications, fentanyl since they also use P450 cytochrome system • 1.0-2.5 mg IV • Onset 30-60 seconds • Time to Peak Effect 3-5 minutes • Duration of Sedation 15-80 minutes

  16. Midazolam • Indications: • Sedation prior to cardioversion and intubation • Maintenance of sedation in mechanically ventilated patients • Pediatric seizure control

  17. Midazolam Adults • Intubation adjunct: • 0.5-5mg IV/IM • may repeat every 5-10 minutes • max 10 mg • Status, cardioversion, pacing, inner ear problems, sedation, muscular spasms: • 0.5-2.5 mg IV, 5mg IM • may repeat every 5-10 mins • max 5mg

  18. Midazolam Pediatric • Intubation: • 0.1-0.2 mg/kg • max 5 mg/dose, repeat PRN for sedation to max of 10 mg • Seizures: • 0.2-0.4 mg/kg IN/PR • IV/IM 0.05-0.2 mg/kg • repeat every 5 mins PRN • Sedation for painful procedures, cardioversion, pacing, muscular spasms, hyperdynamic drug ingestion/exposure: • 0.05-0.1 mg/kg IV/IM/IO • every 5-10 min (2-5 mins if IV) max 2.5 mg

  19. Midazolam Side Effects • Ventilatory Depression caused by decrease in hypoxic drive • Effects greater than for Lorazepam and Diazepam • Exaggerated in presence of other opioids and CNS depressants, COPD, increasing age

  20. Diazepam • Indications: • Seizures/status epilepticus • Sedation pre-cardioversion • Acute anxiety • Skeletal muscle relaxant • Alcohol withdrawal • Vertigo

  21. Diazepam • Seizures: • 2-10 mg slow IV • 5-10 mg PR • max 20 mg • Sedation/cardioversion/pacing/muscle spasm/labyrinthitis/vertigo: • 2-5 mg slow IV every 5-10 mins • max 10mg

  22. Midazolam vs Diazepam • More rapid onset • Greater amnesia • 2 to 3 times as potent • Twice the affinity for benzodiazepine receptor • Greater decrease in blood pressure and heart rate • Systemic vascular resistance • Less post-procedural sedation • Same time to complete recovery

  23. Benzodiazepines

  24. Benzodiazepines

  25. Etomidate: Properties • Anesthetic • Non-narcotic sedative hypnotic • Increases GABA receptors, enhancing inhibitory neurotransmission • Reticular activating system depression • Short acting • Induces sedation & amnesia • No histamine release • Minimal cardiac & respiratory depressive effects

  26. Etomidate: Adverse Effects • ? Decreased ICP • Nausea and vomiting • Myoclonus • Adrenocortical Suppression

  27. Etomidate Indications: • Induction agent for intubation • Pre-medication for cardioversion

  28. Etomidate • Adults & Pediatrics • Intubation: 0.3 mg/kg slow IV over 30-60 seconds, repeat as needed, maximum 0.6mg/kg • Short painful procedures: 0.15 mg/kg slow IV over 30-60 seconds

  29. Etomidate vs Midazolam for Out-of-Hospital Intubation: A Prospective, Randomized TrialAnn Emerg Med. 47(6):525-30, 2006 Jun • Prospective, double blind, randomized • 55 Versed, 55 Etomidate • 75% success rate versed, 76% etomidate • No difference in success rates, incidence of hypotension, number of attempts, perceived difficulty

  30. Opiates

  31. Morphine • Central nervous system depressant • Acts at mu receptors above and at spinal cord • Decrease cardiac preload/afterload • Decreases myocardial oxygen demand • Releases histamine  can cause hypotension

  32. Morphine • Dose: 0.05-0.1 mg/kg IV • Peak: 10-30 minutes • Duration: 2-4 hours

  33. Morphine • Adverse Reactions & Side Effects • CNS: Euphoria, sedation, respiratory depression • Cardiovascular: bradycardia, hypotension • GI: decreased motility, nausea, vomiting • GU: urinary retention • Respiratory: bronchoconstriction, antitussive

  34. Fentanyl • Synthetic opioid derivative • 100x potency of morphine • Highly lipid soluble • Stored in adipose tissue to create a “reservoir” • Low complication rate • Doesn’t release histamine, rarely produces hypotension

  35. Fentanyl • Dose: 1 mcg/kg IV • Onset: Fast • Peak: 2.5-10 minutes • Duration: 30-90 minutes

  36. Fentanyl • Respiratory depression with alcohol or versed • Chest wall rigidity • dose dependent • not reliably antagonized by naloxone

  37. Nitrous Oxide

  38. Nitrous Oxide • Colorless gas • Mixed with 50% oxygen and inhaled • Self-administered by patient • Mild intoxicant, potent analgesic • Disspiates within 2-5 minutes after stopping

  39. Nitrous Oxide • Adverse Reactions • Light-headed • Confusion • Drowsiness • Nausea/vomiting

  40. Nitrous Oxide • Contraindicated: • Altered state of consciousness • Head injury, alcohol ingestion, drug OD • COPD • Pneumothorax • Decompression sickness • Air embolus • Abdominal pain with distension • Pregnancy, except during delivery • Unable to self-administer

  41. Nitrous Oxide • Considerations • Currently not on REMO protocol, but a good drug to know about • Heavier than air, can accumulate at ambulance floor and affect EMS personnel

  42. Patient Restraint • No standing orders • Available through Medical Control: • Age < 70: Haloperidol 5mg mixed with Midazolam 2mg IM • Age > 70: Haloperidol 5mg IM • Repeat

  43. Patient Restraint In 1998 California survey of 490 EMS providers: • 61% recounted assault on the job • 25% reported injury • 37% of injured required medical attention • 95% recounted restraining patient “Exposure of prehospital care providers to violence.” Prehospital Emergency Care. 2(2):127-31, 1998 Apr-Jun.

  44. Dangers to Patients • “Positional Asphyxia During Law Enforcement Transport.” • Am Jrnl of Forensic Med and Path. Reay DR. 13(2):90-7, 1992. • “Met Acidosis in Restraint-Associated Cardiac Arrest: A Case Series.” • Acad Emerg Med. Hick, et al. 6(3):239-44, 1999. • “Sudden Death in Individuals in Hobble Restraints During Paramedic Transport.” • Ann of Emerg Med. Stratton SJ, et al. 25(5):710-12, May 1995.

  45. Patient Restraint • Indications: • Patients at risk of causing physical harm to emergency responders, the public, and/or themselves • Considerations: • Cannot be transported face down • If in police custody with handcuffs on, must beaccompanied by police officer in ambulance to hospital • EMS may only apply “soft restraints”

  46. Haldol • Dopamine blockade in mesocortex and limbic system inhibits psychoses • Extrapyramidal effects (akathisia, dystonia, pseudoparkinsonism) due to dopamine blockade in niagrostriatal pathways • Sedative for psychomotor agitation • Minor anticholinergic and antihistaminic actions rarely cardiovascular, anticholinergic effects • May cause QT prolongation, lower seizure thresholds

  47. Haldol • Indications: • Acute and chronic psychoses • Agitation, aggression • Contraindications: • Parkinson’s • Seizure • Cocaine overdose • Alcoholism • Severe mental/CNS depression • thyrotoxicosis

  48. Haldol • Dosage 5-10mg IM

  49. Summary • Sedation is a dynamic spectrum • Main EMS uses: • Procedures • Restraint • Primary Treatment • Pain management adjunct

More Related